Novo Nordisk launches bidding war with Pfizer for obesity drugmaker Metsera

Danish pharmaceutical giant Novo Nordisk, maker of weight-loss drugs Ozempic and Wegovy, announced Thursday an unsolicited bid to acquire obesity treatment maker Metsera, topping an offer from US rival Pfizer which called the move "reckless."
š Full Story

New Virtue Signal Just Dropped and Even Republicans are Doing it - And Looking Like Clowns! š¤¦š»āāļø
- Handmade costumes crafted for patients at Cincinnati Children's NICU
- Thursday's Final Word
- How guided cognitive training may improve brain performance
- FBI Uses Secret Threat Category for Israeli Criminals Operating in U.S. - Daniel Boguslaw
- Raunchy, R-Rated Comedy Thriller Brings Together Geek Icons For Classic Sci-Fi Terror - Chris Snellgrove
- GitHub's Agent HQ aims to solve enterprises' biggest AI coding problem: Too many agents, no central control

Puppy Prohibition: Ban on Pet Store Sales Kills Pet Stores, But Hasnāt Stopped Puppy Mills.
- Simon Wiesenthal Gala Honoring David Zaslav Turns Into A Room Where It Happens Amid WBD Intrigue - Dominic Patten
- Inside Ring-1T: Ant engineers solve reinforcement learning bottlenecks at trillion scale
- Unlocking Secrets from the Dawn of the Solar System: A Look at Bennu Asteroid's 4.6bn-year-old Dark Dust - Arya Chandran
- When Social Security Recipients Will Get Their Checks in November
- What's next for Vision Pro? Apple should take a cue from Xreal's smart glasses
- Police chase runaway inflatable pumpkin through Ohio town

